ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
Oestrogen versus androgen in HRT for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trial
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 124215" data-attributes="member: 13851"><p>Interpretation</p><p></p><p>Testosterone was well tolerated and as safe as oestrogen for hormone-replacement therapy. Testosterone can be an alternative hormone substitution in CAIS, especially for women with reduced sexual functioning.</p><p></p><p></p><p>Research in context</p><p></p><p><strong>Evidence before this study</strong></p><p>Patients with complete androgen insensitivity syndrome (CAIS) after gonadectomy report significantly reduced psychological wellbeing and sexual satisfaction.</p><p></p><p><strong>Added value of this study</strong></p><p>We showed that testosterone is a well tolerated hormone treatment for patients with CAIS. Serum hormone profiles correspond to typically male reference ranges, which is similar to those of patients with CAIS before gonadectomy. We found that patients with CAIS can benefit from continuous hormone substitution. However, compared with oestradiol, testosterone only improved sexual functioning. Yet sexual satisfaction is a relevant topic in CAIS, as reflected by very low scores on sexual functioning measured with the Female Sexual Function Index. Intra-individual differences were detected, with some participants gaining greater benefit from testosterone treatment.</p><p></p><p><strong>Implications of all the available evidence</strong></p><p>Patients with CAIS must be supplied with continuous hormone treatment. However, a relevant percentage of patients with CAIS do not receive adequate hormone substitution. Poor adherence to life-long medication because of lack of evidence of benefit and the inadequate medical expertise of caregivers contribute to this phenomenon. Testosterone treatment can be an alternative to oestradiol, especially to improve sexual functioning. Individual trends during both treatments must be analysed and correlated to endocrine profiles in blood and urine in further analyses.</p></blockquote><p></p>
[QUOTE="madman, post: 124215, member: 13851"] Interpretation Testosterone was well tolerated and as safe as oestrogen for hormone-replacement therapy. Testosterone can be an alternative hormone substitution in CAIS, especially for women with reduced sexual functioning. Research in context [B]Evidence before this study[/B] Patients with complete androgen insensitivity syndrome (CAIS) after gonadectomy report significantly reduced psychological wellbeing and sexual satisfaction. [B]Added value of this study[/B] We showed that testosterone is a well tolerated hormone treatment for patients with CAIS. Serum hormone profiles correspond to typically male reference ranges, which is similar to those of patients with CAIS before gonadectomy. We found that patients with CAIS can benefit from continuous hormone substitution. However, compared with oestradiol, testosterone only improved sexual functioning. Yet sexual satisfaction is a relevant topic in CAIS, as reflected by very low scores on sexual functioning measured with the Female Sexual Function Index. Intra-individual differences were detected, with some participants gaining greater benefit from testosterone treatment. [B]Implications of all the available evidence[/B] Patients with CAIS must be supplied with continuous hormone treatment. However, a relevant percentage of patients with CAIS do not receive adequate hormone substitution. Poor adherence to life-long medication because of lack of evidence of benefit and the inadequate medical expertise of caregivers contribute to this phenomenon. Testosterone treatment can be an alternative to oestradiol, especially to improve sexual functioning. Individual trends during both treatments must be analysed and correlated to endocrine profiles in blood and urine in further analyses. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
Oestrogen versus androgen in HRT for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trial
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top